The SNP of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene's I148M variant is implicated in NAFLD [35], showing associations with reduced de novo lipogenesis, increased expression of SREBP-1c, and higher risks of steatosis and liver fibrosis [36]. The gene discussed is PNPLA3; the disease is steatosis.